SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-019493
Filing Date
2008-03-20
Accepted
2008-03-20 15:35:43
Documents
1
Period of Report
2008-03-18

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b69305m2.html 3  
1 MAIN DOCUMENT DESCRIPTION b69305m2.xml 3 3831
  Complete submission text file 0001209191-08-019493.txt   6602
Mailing Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168
Business Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168 212-682-3096
Lev Pharmaceuticals Inc (Issuer) CIK: 0001144062 (see all company filings)

IRS No.: 880211496 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON ST. SUITE 401 BOSTON MA 02116
Business Address 535 BOYLSTON ST. SUITE 401 BOSTON MA 02116 617-375-3000
Mast Credit Opportunities I Master Fund LTD (Reporting) CIK: 0001336625 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-32947 | Film No.: 08702226

Mailing Address 535 BOYLSTON STREET SUITE 401 BOSTON MA 02116
Business Address 535 BOYLSTON STREET SUITE 401 BOSTON MA 02116 617-375-3000
Mast Capital Management LLC (Reporting) CIK: 0001429074 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-32947 | Film No.: 08702225